Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Clinical trial NCT06545942 · RECRUITING

Trial details

NCT number: NCT06545942
Sponsor: MOMA Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Metastatic Solid Tumor Prostate Cancer Pancreas Cancer Breast Cancer Ovarian Cancer Homologous Recombination Deficiency

Start date: 2024-08-13
Primary completion: 2027-05-31
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.